(0.30%) 5 115.20 points
(0.40%) 38 393 points
(0.41%) 15 993 points
(-1.61%) $82.50
(4.84%) $2.02
(0.20%) $2 351.90
(0.19%) $27.59
(4.19%) $960.70
(-0.20%) $0.933
(-0.37%) $10.98
(-0.52%) $0.796
(1.69%) $93.42
0.00% $ 0.203
Live Chart Being Loaded With Signals
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform...
Stats | |
---|---|
Tagesvolumen | 1.75M |
Durchschnittsvolumen | 263 314 |
Marktkapitalisierung | 2.33M |
EPS | $0 ( 2024-03-18 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0194 |
ATR14 | $0.141 (69.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-05 | Lau Johnson Yiu Nam | Buy | 8 382 | Common Stock |
2023-05-05 | Kwan Rudolf | Buy | 3 603 | Common Stock |
2023-05-05 | Cook Timothy Devere | Buy | 368 | Common Stock |
2023-04-21 | Wu Jinn | Buy | 6 513 | Common Stock |
2023-04-21 | Vierling John | Buy | 6 513 | Common Stock |
INSIDER POWER |
---|
94.72 |
Last 100 transactions |
Buy: 1 577 577 | Sell: 76 746 |
Volumen Korrelation
Athenex Inc Korrelation
10 Am meisten positiv korreliert | |
---|---|
RUBY | 0.962 |
VERU | 0.948 |
AGIL | 0.946 |
CYXT | 0.946 |
GLG | 0.944 |
PRPL | 0.943 |
TTGT | 0.943 |
TCPC | 0.941 |
NCBS | 0.941 |
BSBK | 0.939 |
10 Am meisten negativ korreliert | |
---|---|
SWAV | -0.955 |
ISRG | -0.954 |
HBIO | -0.95 |
LMRKO | -0.948 |
TYHT | -0.946 |
VRTX | -0.945 |
CREX | -0.943 |
LMRKP | -0.942 |
ALXN | -0.942 |
ITCI | -0.94 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Athenex Inc Korrelation - Währung/Rohstoff
Athenex Inc Finanzdaten
Annual | 2022 |
Umsatz: | $102.82M |
Bruttogewinn: | $26.70M (25.97 %) |
EPS: | $-15.13 |
FY | 2022 |
Umsatz: | $102.82M |
Bruttogewinn: | $26.70M (25.97 %) |
EPS: | $-15.13 |
FY | 2021 |
Umsatz: | $120.18M |
Bruttogewinn: | $37.78M (31.43 %) |
EPS: | $-1.920 |
FY | 2020 |
Umsatz: | $144.39M |
Bruttogewinn: | $49.04M (33.96 %) |
EPS: | $-1.720 |
Financial Reports:
No articles found.
Athenex Inc
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in cutaneous angiosarcoma, advanced gastric cancer, and advanced solid malignancies. It also offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis. In addition, the company is developing KUR-501, an autologous product that is in a phase I clinical trial for treating children with relapsed-refractory (R/R) high risk neuroblastoma; KUR-502, an allogeneic product, which is in a phase I clinical trial for treating adults with R/R CD19 positive malignancies, including B cell lymphoma, acute lymphoblastic leukemia, and chronic lymphocytic leukemia; and KUR-503, an allogeneic product that is in preclinical development for advanced hepatocellular carcinomas, as well as TCRT-ESO-A2, an autologous T cell receptor (TCR)-T cell therapy that is in phase 1 clinical trial for solid tumors. Further, it is developing dual absorption enhancers to inhibit the P-gp transporter and the cytochrome p450 3A enzymes within the gastrointestinal tract; and has a portfolio of TCRs that recognize hotspot mutations in p53, KRAS, and EGFR genes for multiple tumors. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.